ArticleJournal of clinical medicine2024

Clinical Utility of Recently Food and Drug Administration-Approved IntelliSep Test (Sepsis Biomarker) for Early Diagnosis of Sepsis: Comparison with Other Biomarkers.

Nima Sarani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.